Sacubitril/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal miR‐181a in a rodent chronic myocardial infarction …
… Heart failure (HF) is the leading cause of hospital admission … function and remodeling, we
used a chronic HF model post … to enhance the cardiovascular function post myocardial injury. …
used a chronic HF model post … to enhance the cardiovascular function post myocardial injury. …
Effect of sacubitril/valsartan on the prognosis of patients with heart failure with midrange ejection fraction
Z Yongyue, XU Zhaolong - J Clin Cardiol, 2021 - lcmwen.whuhzzs.com
… of prognosis of sacubitril/valsartan in the patients with heart failure with midrange ejection
fraction… The control group used conventional heart failure treatment(including the application of …
fraction… The control group used conventional heart failure treatment(including the application of …
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
S Frantz, MJ Hundertmark… - European heart …, 2022 - academic.oup.com
… be used to stratify individuals at risk for remodelling, a patient … In PROVE-HF, sacubitril/valsartan
in HFrEF patients led to … in patients at risk for heart failure after myocardial infarction in …
in HFrEF patients led to … in patients at risk for heart failure after myocardial infarction in …
[HTML][HTML] Targeted imaging of angiogenesis post-myocardial infarction predicts development of heart failure
AJ Sinusas - Journal of Nuclear Cardiology, 2023 - Springer
… In another rat MI study, sacubitril/valsartan was shown to induce an uptake of 99m Tc-… was
used in a pilot clinical SPECT imaging studies in nine patients with heart failure who had been …
used in a pilot clinical SPECT imaging studies in nine patients with heart failure who had been …
To Evaluate the'Real World'Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left Ventricular Dysfunction: Tenacity Study.
K Sharma, H Desai, N Sharm, M Laddha… - The Journal of the …, 2022 - europepmc.org
… heart failure and are well studied in Acute Coronary Syndromes (ACS). There is paucity of
data of Bisoprolol in acute ICU setting in patients admitted with left ventricular … we use a word-…
data of Bisoprolol in acute ICU setting in patients admitted with left ventricular … we use a word-…
[HTML][HTML] Sympathetic activation and arrhythmogenesis after myocardial infarction: Where do we stand?
KC Zekios, ET Mouchtouri, P Lekkas, DN Nikas… - … of Cardiovascular …, 2021 - mdpi.com
… in post-infarction heart failure. In this regard, aldosterone inhibitors, sacubitril/valsartan and
… ventricular arrhythmogenesis post-myocardial infarction, focusing on sympathetic activation. …
… ventricular arrhythmogenesis post-myocardial infarction, focusing on sympathetic activation. …
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
GG Sokos, A Raina - Vascular Health and Risk Management, 2020 - Taylor & Francis
… valsartan/valsartan has yet to be determined, its early use … /valsartan therapy following an
ischemic insult and revascularization (peri-myocardial infarction) or post-myocardial infarction …
ischemic insult and revascularization (peri-myocardial infarction) or post-myocardial infarction …
[HTML][HTML] Effect of candesartan treatment on echocardiographic indices of cardiac remodeling in post-myocardial infarction patients
H Tezcan, A Tunçez, K Demir, BB Altunkeser… - Revista da Associação …, 2023 - SciELO Brasil
SciELO - Brasil - Effect of candesartan treatment on echocardiographic indices of cardiac
remodeling in post-myocardial infarction patients Effect of candesartan treatment on …
remodeling in post-myocardial infarction patients Effect of candesartan treatment on …
The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
KH Akhtar, MS Khan, SJ Baron, S Zieroth… - … in Cardiovascular …, 2024 - Elsevier
… ACEIs should be used in patients presenting with AMI who do not have a contraindication
to … >14,000 patients with AMI and HF to valsartan, captopril, or combination of valsartan and …
to … >14,000 patients with AMI and HF to valsartan, captopril, or combination of valsartan and …